Recipharm has entered into a collaboration agreement with Vetcare for the development and manufacture of a parenteral veterinary product. Recipharm will develop the product at its site in Solna, Sweden and the commercial manufacture will take place at its site in Monts, France.
 
Maria Lundberg, general manager, Recipharm Pharmaceutical Development, said, “We are pleased to have entered into this collaboration with Vetcare. This project is perfectly suited to Recipharm as it allows us to demonstrate our expertise in formulation and analytical method development with a challenging formulation before performing technology transfer to commercial manufacturing.”
 
“Michel Saudemon, general manager of Recipharm in Monts, said, “This project is excellent news and is a perfect fit for our new smaller scale flexible manufacturing facility, which will come on line next year.”